76 related articles for article (PubMed ID: 38539430)
1. Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández JA; Martín A; Alcoceba M; Sarasquete ME; Rodríguez-Vicente A; Heras C; de Las Heras N; Fisac R; García de Coca A; de la Fuente I; Hernández-Sánchez M; Recio I; Galende J; Martín-Núñez G; Alonso JM; Hernández-Rivas JM; González M
Biomed Res Int; 2014; 2014():257517. PubMed ID: 24790994
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.
Michelerio A; Rubatto M; Roccuzzo G; Coscia M; Quaglino P; Tomasini C
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792476
[No Abstract] [Full Text] [Related]
3. [Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia].
Qiu TL; Li JY; Xia Y
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):197-202. PubMed ID: 38604800
[TBL] [Abstract][Full Text] [Related]
4. Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
Rozovski U; Keating MJ; Estrov Z
Acta Haematol; 2018; 140(1):51-54. PubMed ID: 30114695
[TBL] [Abstract][Full Text] [Related]
5. Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Angotzi F; Cellini A; Ruocco V; Cavarretta CA; Zatta I; Serafin A; Pravato S; Pagnin E; Bonaldi L; Frezzato F; Facco M; Piazza F; Trentin L; Visentin A
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539430
[TBL] [Abstract][Full Text] [Related]
6. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
[TBL] [Abstract][Full Text] [Related]
8. Association of Cytogenetics Aberrations and
Muñoz-Novas C; González-Gascón-Y-Marín I; Figueroa I; Sánchez-Paz L; Pérez-Carretero C; Quijada-Álamo M; Rodríguez-Vicente AE; Infante MS; Foncillas MÁ; Landete E; Churruca J; Marín K; Ramos V; Sánchez Salto A; Hernández-Rivas JÁ
Glob Med Genet; 2024 Jan; 11(1):59-68. PubMed ID: 38348157
[TBL] [Abstract][Full Text] [Related]
9. Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Raponi S; Ilari C; Della Starza I; Cappelli LV; Cafforio L; Piciocchi A; Arena V; Mariglia P; Mauro FR; Gentile M; Cutrona G; Moia R; Favini C; Morabito F; Rossi D; Gaidano G; Guarini A; Del Giudice I; Foà R
Br J Haematol; 2020 Jun; 189(5):853-859. PubMed ID: 32064595
[TBL] [Abstract][Full Text] [Related]
10. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
11. Updates of the ERIC recommendations on how to report the results from immunoglobulin heavy variable gene analysis in chronic lymphocytic leukemia.
Chatzikonstantinou T; Agathangelidis A; Chatzidimitriou A; Tresoldi C; Davis Z; Giudicelli V; Kossida S; Belessi C; Rosenquist R; Ghia P; Langerak AW; Davi F; Stamatopoulos K;
Leukemia; 2024 Mar; 38(3):679-680. PubMed ID: 38366088
[No Abstract] [Full Text] [Related]
12. Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon.
Ayoub G; Sinan H; Kourie HR; Kattan J; Nasr F; Karak FE; Wakim J; Ghosn M; Chahine G; Farra C; Chebly A
Future Oncol; 2023 Sep; 19(29):1991-2002. PubMed ID: 37795707
[No Abstract] [Full Text] [Related]
13. Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up.
Thompson PA; Bazinet A; Wierda WG; Tam CS; O'Brien SM; Saha S; Peterson CB; Plunkett W; Keating MJ
Blood; 2023 Nov; 142(21):1784-1788. PubMed ID: 37595283
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Severin F; Mouawad N; Ruggeri E; Visentin A; Martinello L; Pagnin E; Trimarco V; Pravato S; Angotzi F; Facco M; Trentin L; Frezzato F
Br J Haematol; 2023 Oct; 203(2):224-236. PubMed ID: 37495265
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
